Gene amplification in neoplasia: A cytogenetic survey of 80 131 cases
Genes, Chromosomes and Cancer · 2024-01 · 63 (1)
DOI: 10.1002/gcc.23214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, online erschienen am 05.12.2023. Verfasst von Nils Mandahl und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Sarcoma, Neuroblastoma, Bone Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Swedish Childhood Cancer Foundation, Cancerfonden.
Abstract (Originalsprache)
Gene amplification is a crucial process in cancer development, leading to the overexpression of oncogenes. It manifests cytogenetically as extrachromosomal double minutes (dmin), homogeneously staining regions (hsr), or ring chromosomes (r). This study investigates the prevalence and distribution of these amplification markers in a survey of 80 131 neoplasms spanning hematologic disorders, and benign and malignant solid tumors. The study reveals distinct variations in the frequency of dmin, hsr, and r among different tumor types. Rings were the most common (3.4%) sign of amplification, followed by dmin (1.3%), and hsr (0.8%). Rings were particularly frequent in malignant mesenchymal tumors, especially liposarcomas (47.5%) and osteosarcomas (23.4%), dmin were prevalent in neuroblastoma (30.9%) and pancreatic carcinoma (21.9%), and hsr frequencies were highest in head and neck carcinoma (14.0%) and neuroblastoma (9.0%). Combining all three amplification markers (dmin/hsr/r), malignant solid tumors consistently exhibited higher frequencies than hematologic disorders and benign solid tumors. The structural characteristics of these amplification markers and their potential role in tumorigenesis and tumor progression highlight the complex interplay between cancer‐initiating gene‐level alterations, for example, fusion genes, and subsequent amplification dynamics. Further research integrating cytogenetic and molecular approaches is warranted to better understand the underlying mechanisms of these amplifications, in particular, the enigmatic question of why certain malignancies display certain types of amplification. Comparing the present results with molecular genetic data proved challenging because of the diversity in definitions of amplification across studies. This study underscores the need for standardized definitions in future work.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
- Division of Laboratory Medicine, Department of Clinical Genetics and Pathology, University Hospital, Lund, Sweden.
ORCID-Profile: Fredrik Mertens, Felix Mitelman
Förderung
- Swedish Cancer Society
- Swedish Childhood Cancer Foundation
- Cancerfonden
- Barncancerfonden
Zitieren
APA
Mandahl, N., Mertens, F., & Mitelman, F. (2024). Gene amplification in neoplasia: A cytogenetic survey of 80 131 cases. Genes, Chromosomes and Cancer, 63(1). https://doi.org/10.1002/gcc.23214
Vancouver
Mandahl N, Mertens F, Mitelman F. Gene amplification in neoplasia: A cytogenetic survey of 80 131 cases. Genes, Chromosomes and Cancer. 2024;63(1). doi:10.1002/gcc.23214
BibTeX
@article{Mandahl2024,
author = {Mandahl, Nils and Mertens, Fredrik and Mitelman, Felix},
title = {Gene amplification in neoplasia: A cytogenetic survey of 80 131 cases},
journal = {Genes, Chromosomes and Cancer},
year = {2024},
volume = {63},
number = {1},
doi = {10.1002/gcc.23214}
}
EUVIMED